Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ARTENIMOL\PIPERAQUINE: 37 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
37
Total FAERS Reports
1 (2.7%)
Deaths Reported
30
Hospitalizations
37
As Primary/Secondary Suspect

Active Ingredient: ARTENIMOL\PIPERAQUINE PHOSPHATE ·

First Report: 2016 · Latest Report: 20250505

What Are the Most Common ARTENIMOL\PIPERAQUINE Side Effects?

#1 Most Reported
Haemolytic anaemia
20 reports (54.1%)
#2 Most Reported
Agranulocytosis
7 reports (18.9%)
#3 Most Reported
Thrombocytopenia
4 reports (10.8%)

All ARTENIMOL\PIPERAQUINE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Haemolytic anaemia 20 54.1% 0 20
Agranulocytosis 7 18.9% 0 7

Who Reports ARTENIMOL\PIPERAQUINE Side Effects? Age & Gender Data

Gender: 87.5% female, 12.5% male. Average age: 39.1 years. Most reports from: FR. View detailed demographics →

Is ARTENIMOL\PIPERAQUINE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2016 3 0 0
2017 1 0 1
2018 13 0 13
2019 5 0 3
2020 4 0 4
2021 7 0 6
2024 1 0 1
2025 1 0 1

View full timeline →

What Is ARTENIMOL\PIPERAQUINE Used For?

IndicationReports
Plasmodium falciparum infection 19
Malaria 15

Official FDA Label for ARTENIMOL\PIPERAQUINE

Official prescribing information from the FDA-approved drug label.